Cannabis Recreational White Paper 
Veriheal
AUGUST 16, 2023
In the fast-paced, data-driven world of the cannabis industry, partnerships are crucial to success. They have co-published an insightful white paper, “The State of the Pre-Roll Industry,” which provides a comprehensive overview of the rising popularity and potential of pre-rolls. Here are some of the findings of the research.
MGC Pharma
FEBRUARY 15, 2018
What will unrestricted access to Medicinal Cannabis look like in Australia? A word from Ron Lipsky, Manager of Business Development and International Relations at MGC Pharmaceuticals Right now in Australia, access to Cannabis-based treatments is heavily restricted. Australia is a vital player in the global Medicinal Cannabis game.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
SpeedWeed
FEBRUARY 20, 2021
French hemp group – the Medical Cannabis and Wellness Hemp Union (SPC) – estimates these changes could transform French CBD into a €1bn industry by 2023. This comes as the country is launching a 3,000-patient medical cannabis trial, and scores of new CBD stores are opening following the crucial KanaVape judgement late last year.
Cannabis Law Report
NOVEMBER 26, 2019
Given the nascent nature of the cannabis industry—particularly here in Australia—it can be tough to separate the wheat from the chaff. For these reasons, FreshLeaf predicts that the Australian cannabis industry will hit $50 million in annualized revenue by the end of the year. After all, a good ship is useless without a great captain.
Cannabis Law Report
JANUARY 10, 2020
LOS ANGELES–(BUSINESS WIRE)–Jan 9, 2020– Oasis Intelligence officially launched today, offering brand marketers in the cannabis and hemp industry, as well as related sectors, a much needed tool: unprecedented access to consumer insights at scale. Simple access to cannabis is the initial driver of sales.
Cannabis Law Report
APRIL 24, 2019
CPA’s “ PUBLISHER: CANNABIS LAW REPORT. – It is fascinating to step back and observe how the mindset of many in the cannabis industry seems to work. 280E is effectively repealed and cannabis businesses are no longer subject to the broad disallowance of expenses. Federal Legalization – Then What?
Cannabis Law Report
JUNE 2, 2022
State legalization of cannabis (i.e., marijuana) for medical and/or recreational use has spurred many questions regarding exposure concerns and drug testing concerns (e.g., what constitutes positive cannabis tests and how do results relate to impairment). Cannabis Impairment & Regulations. Introduction.
Expert insights. Personalized for you.
98 
Let's personalize your content